Results 11 to 20 of about 410,228 (317)
Prescribing databases can be used to monitor trends in opioid analgesic prescribing in Australia [PDF]
Australian and New Zealand Journal of Public Health, 2013 Objective: There has been increased use of prescription opioid analgesics in Australia in the past 20 years with increasing evidence of related problems. A number of data sources collect information about the dispensed prescribing for opioid medications,
American Academy of Pain Medicine and the American Pain Society +36 more
core +2 more sources
PAIN Reports, 2018 . Introduction:. Cognitive performance and inflammation are altered in people with chronic low back pain (CLBP). Yet, the magnitude of these changes has been unclear because of the potential influence of opioid analgesics. Objectives:.
Georgia C. Richards +6 more
doaj +2 more sources
Impact of a Mandatory Prescription Drug Monitoring Program on Prescription of Opioid Analgesics by Dentists. [PDF]
PLoS ONE, 2015 Prescription Drug Monitoring Programs (PDMP) are statewide databases that collect data on prescription of controlled substances. New York State mandates prescribers to consult the PDMP registry before prescribing a controlled substance such as opioid ...
Linda Rasubala +4 more
doaj +2 more sources
Opioid peptide-derived analgesics [PDF]
The AAPS Journal, 2005 Two recent developments of opioid peptide-based analgesics are reviewed. The first part of the review discusses the dermorphin-derived, cationic-aromatic tetrapeptide H-Dmt-D-Arg-Phe-Lys-NH(2) ([Dmt(1)]DALDA, where Dmt indicates 2',6'-dimethyltyrosine), which showed subnanomolar mu receptor binding affinity, extraordinary mu receptor selectivity, and ...
Peter W. Schiller
openaire +5 more sources
Clinical practice guideline for deprescribing opioid analgesics: summary of recommendations
Medical Journal of Australia, 2023 Long term opioids are commonly prescribed to manage pain. Dose reduction or discontinuation (deprescribing) can be challenging, even when the potential harms of continuation outweigh the perceived benefits.
A. Langford +16 more
semanticscholar +1 more source
Opioid analgesics for nociceptive cancer pain: A comprehensive review
Ca, 2023 Pain is one of the most burdensome symptoms in people with cancer, and opioid analgesics are considered the mainstay of cancer pain management. For this review, the authors evaluated the efficacy and toxicities of opioid analgesics compared with placebo,
Christina Abdel Shaheed +8 more
semanticscholar +1 more source
Subtypes in Patients Taking Prescribed Opioid Analgesics and Their Characteristics: A Latent Class Analysis. [PDF]
Front Psychiatry, 2022 BackgroundOwing to their pharmacological properties the use of opioid analgesics carries a risk of abuse and dependence, which are associated with a wide range of personal, social, and medical problems.
Rauschert C +5 more
europepmc +2 more sources
JAMA Network Open, 2021 Key Points Question How has prescribing of opioid analgesics and buprenorphine for opioid use disorder changed throughout the COVID-19 pandemic? Findings This cross-sectional study analyzed prescriptions from 90 420 353 patients and found that from March
J. Currie +3 more
semanticscholar +1 more source
Health Promotion and Chronic Disease Prevention in Canada, 2021 IntroductionHarms caused by prescription opioid analgesics (POAs) have been identified as a major international public health concern. Recent statistics show rising numbers of opioid-related deaths across Canada.
Joshua Goodwin, Susan Kirkland
doaj +1 more source
Kidney Diseases, 2023 Introduction: Comprehensive data on the risk of hospital-acquired (HA) acute kidney injury (AKI) among adult users of opioid analgesics are lacking.
Mingjing Pi +27 more
doaj +1 more source